AngioDynamics vs Cerus
ANGO and CERS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ANGO and CERS compare
AngioDynamics is the larger company, worth 1.2 times as much as Cerus ($522M against $427M).
Cerus keeps more of each dollar of sales as profit, with a net margin of −2.9% compared with −10.1% at AngioDynamics.
AngioDynamics scores higher on the StockData Score (12 against 6 for Cerus), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ANGO | CERS |
|---|---|---|
| Size and price | ||
| Market cap | $522M | $427M |
| Share price | $12.42 | $2.12 |
| Change, 1 year | 1.1% | 32.5% |
| Change, 5 years | −56.5% | −70.6% |
| Beta (5Y) | 0.34 | 1.72 |
| Employees | 632 | 275 |
| StockData Score | ||
| Total score | 12 (better) | 6 |
| Valuation score | 2 | 2 |
| Growth score | 2 (better) | 0 |
| Performance score | 3 | 3 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.6× (better) | 1.7× |
| P/B | 3.2× (better) | 5.6× |
| P/FCF | 362× (better) | 865× |
| FCF yield | 0.28% (better) | 0.12% |
| Fair value | $13.24 | $2.72 |
| Margin of safety | 6.2% | 22.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 8.2% | – |
| Revenue growth, 5Y average | 1.9% | 15.4% (better) |
| Profitability | ||
| Gross margin | 55.7% | – |
| Operating margin | −11.2% | −0.97% (better) |
| Net margin | −10.1% | −2.9% (better) |
| FCF margin | 0.44% (better) | 0.19% |
| Return on equity | −19.2% | −10.7% (better) |
| Return on invested capital | −21.4% (better) | −966% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −0.4× |
| Current ratio | 2.40 (better) | 1.96 |
| Altman Z-score | 2.54 (better) | −3.78 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.01% |
| Shareholder yield | 0.00% | 0.01% (better) |
| Ownership | ||
| Held by institutions | 91.0% | 74.8% |
| Held by insiders | 5.8% | 6.0% |
| Insider net buying, 12 months | −$655K (better) | −$3.2M |
| Short interest, % of float | 5.1% | 7.7% |
Go deeper
- ANGO stock overview
- ANGO income statement
- ANGO valuation and score
- CERS stock overview
- CERS income statement
- CERS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.